Excess morbidity and mortality associated with underuse of estrogen replacement therapy in premenopausal women who undergo surgical menopause
American Journal of Obstetrics and Gynecology · 2024-06 · 230 (6) · 653.e1-653.e17
DOI: 10.1016/j.ajog.2024.02.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Obstetrics and Gynecology, 2024-06. Verfasst von Jennifer S Ferris und 7 weiteren Autor:innen. Beteiligte Einrichtung: XXX, Columbia University Vagelos College of Physicians and Surgeons, New York, NY. Hauptthemen laut MEDLINE: Hysterectomy, Premenopause, Breast Neoplasms, Estrogen Replacement Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Contrary to clinical guidelines, there has been a decrease over time in estrogen therapy use in premenopausal women undergoing bilateral oophorectomy for benign indications. OBJECTIVE: This study aimed to estimate the excess morbidity and mortality associated with current patterns of estrogen therapy use in women who undergo bilateral oophorectomy with hysterectomy for benign indications. STUDY DESIGN: We developed 2 Bayesian sampling Markov state-transition models to estimate the excess disease incidence (incidence model) and mortality (mortality model). The starting cohort for both models were women who had undergone bilateral oophorectomy with hysterectomy for benign indications at the age of 45 to 49 years. The models tracked outcomes in 5-year intervals for 25 years. The incidence model estimated excess incidence of breast cancer, lung cancer, colorectal cancer, coronary heart disease, and stroke, whereas the mortality model estimated excess mortality due to breast cancer, lung cancer, coronary heart disease, and all-other-cause mortality. The models compared current rates of estrogen therapy use with optimal (100%) use and calculated the mean difference in each simulated outcome to determine excess disease incidence and death. RESULTS: By 25 years after bilateral oophorectomy with hysterectomy, there were an estimated 94 (95% confidence interval, -158 to -23) fewer colorectal cancer cases, 658 (95% confidence interval, 339-1025) more coronary heart disease cases, and 881 (95% confidence interval, 402-1483) more stroke cases. By 25 years after bilateral oophorectomy with hysterectomy, there were an estimated 189 (95% confidence interval, 59-387) more breast cancer deaths, 380 (95% confidence interval, 114-792) more coronary heart disease deaths, and 759 (95% confidence interval, 307-1527) more all-other-cause deaths. In sensitivity analyses where we defined estrogen therapy use as a duration of >2 years of use, these differences increased >2-fold. CONCLUSION: Underuse of estrogen therapy in premenopausal women who undergo oophorectomy is associated with substantial excess morbidity and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- XXX, Columbia University Vagelos College of Physicians and Surgeons, New York, NY.
- XXX, Joseph L. Mailman School of Public Health, Columbia University, New York, NY; XXX, Herbert Irving Comprehensive Cancer Center, New York, NY.
- XXX, Columbia University Vagelos College of Physicians and Surgeons, New York, NY; XXX, Herbert Irving Comprehensive Cancer Center, New York, NY; XXX, NewYork-Presbyterian Hospital, New York, NY.
- XXX, Columbia University Vagelos College of Physicians and Surgeons, New York, NY; XXX, Joseph L. Mailman School of Public Health, Columbia University, New York, NY; XXX, Herbert Irving Comprehensive Cancer Center, New…
- XXX, Columbia University Vagelos College of Physicians and Surgeons, New York, NY; XXX, Herbert Irving Comprehensive Cancer Center, New York, NY; XXX, NewYork-Presbyterian Hospital, New York, NY. Electronic address: jw2…
Zitieren
APA
Ferris, J. S., Suzuki, Y., Prest, M. T., Chen, L., Elkin, E. B., Hur, C., Hershman, D. L., & Wright, J. D. (2024). Excess morbidity and mortality associated with underuse of estrogen replacement therapy in premenopausal women who undergo surgical menopause. American Journal of Obstetrics and Gynecology, 230(6), 653.e1-653.e17. https://doi.org/10.1016/j.ajog.2024.02.007
Vancouver
Ferris JS, Suzuki Y, Prest MT, Chen L, Elkin EB, Hur C, et al. Excess morbidity and mortality associated with underuse of estrogen replacement therapy in premenopausal women who undergo surgical menopause. American Journal of Obstetrics and Gynecology. 2024;230(6):653.e1-653.e17. doi:10.1016/j.ajog.2024.02.007
BibTeX
@article{Ferris2024,
author = {Ferris, Jennifer S and Suzuki, Yukio and Prest, Matthew T and Chen, Ling and Elkin, Elena B and Hur, Chin and Hershman, Dawn L and Wright, Jason D},
title = {Excess morbidity and mortality associated with underuse of estrogen replacement therapy in premenopausal women who undergo surgical menopause},
journal = {American Journal of Obstetrics and Gynecology},
year = {2024},
volume = {230},
number = {6},
pages = {653.e1--653.e17},
doi = {10.1016/j.ajog.2024.02.007}
}
EUVIMED